
Lexaria Bioscience Corp.
LEXXHealthcare|Biotechnology|CA
$4.50
+0.33 (+7.91%)
Tangible Book / Share
$2.42
Cash / Share
$2.19
Next Earnings Report
Nov 24, 2026
EPS est. -$0.90 · Revenue est. $50.0K
Financing Filings (last 12 months)
7
Shelf registrations / offering prospectuses — latest Oct 13, 2026 (424B3). Possible dilution.
Upcoming Data Readouts (0)
No upcoming completion dates found in active trials.
Recent Press Releases
Lexaria's Human Study GLP-1-H26-7 Reaches Full Enrollment and Continues Dosing on Schedule
Oct 21, 2026 · Accesswire
Lexaria Announces Results from Animal Study GLP-1-A26-1
Oct 15, 2026 · Accesswire
GLP-1 Weight-Loss/Diabetes Industries Continue Transition to Oral Medications
Oct 6, 2026 · Accesswire
Lexaria Updates Financial Position
Sep 17, 2026 · Accesswire
Lexaria Announces Closing of Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
Sep 9, 2026 · Accesswire
Lexaria Announces Exercise of Warrants for Approximately $5.9 Million in Gross Proceeds
Sep 8, 2026 · Accesswire
Lexaria Receives USD$2.6 Million Tax Rebate Payment
Sep 1, 2026 · Accesswire
DehydraTECH(TM)-enhanced Amycretin and Retatrutide Yield Significant Absorption Improvements in Lexaria's 2026 Animal Study #2
Aug 24, 2026 · Accesswire
Lexaria Enters a Material Transfer Agreement With PegBio
Aug 13, 2026 · Accesswire
SEC Filings (57)
Last two years from EDGAR. Insider Form 4s are on the Ownership tab.
| Filed | Form | What it is | Links |
|---|---|---|---|
| Oct 13, 2026 | EFFECT | DocumentIndex | |
| Oct 13, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Oct 2, 2026 | S-3 | Shelf registration | DocumentIndex |
| Sep 21, 2026 | D | DocumentIndex | |
| Sep 9, 2026 | 8-K | Material event | DocumentIndex |
| Sep 1, 2026 | 8-K | Material event | DocumentIndex |
| Aug 17, 2026 | 8-K | Material event | DocumentIndex |
| Aug 10, 2026 | 8-K | Material event | DocumentIndex |
| Jul 30, 2026 | 8-K | Material event | DocumentIndex |
| Jul 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Apr 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Feb 6, 2026 | 8-K | Material event | DocumentIndex |
| Jan 28, 2026 | 8-K | Material event | DocumentIndex |
| Jan 28, 2026 | S-8 | Employee stock plan | DocumentIndex |
| Jan 14, 2026 | EFFECT | DocumentIndex | |
| Jan 14, 2026 | 424B3 | Offering prospectus | DocumentIndex |
| Jan 14, 2026 | 25-NSE | DocumentIndex | |
| Jan 13, 2026 | 10-Q | Quarterly report | DocumentIndex |
| Dec 29, 2025 | S-3 | Shelf registration | DocumentIndex |
| Dec 19, 2025 | D | DocumentIndex | |
| Dec 16, 2025 | 8-K | Material event | DocumentIndex |
| Dec 16, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Dec 10, 2025 | DEF 14A | Proxy / shareholder vote | DocumentIndex |
| Dec 9, 2025 | EFFECT | DocumentIndex | |
| Dec 9, 2025 | 424B3 | Offering prospectus | DocumentIndex |
| Dec 8, 2025 | EFFECT | DocumentIndex | |
| Dec 5, 2025 | POS AM | DocumentIndex | |
| Dec 5, 2025 | S-1/A | IPO / offering registration | DocumentIndex |
| Nov 28, 2025 | 10-K | Annual report | DocumentIndex |
| Oct 14, 2025 | S-1 | IPO / offering registration | DocumentIndex |
| Oct 1, 2025 | D | DocumentIndex | |
| Sep 29, 2025 | 8-K | Material event | DocumentIndex |
| Sep 29, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Sep 25, 2025 | 8-K | Material event | DocumentIndex |
| Jul 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Jun 12, 2025 | 8-K | Material event | DocumentIndex |
| Apr 28, 2025 | 8-K | Material event | DocumentIndex |
| Apr 28, 2025 | 424B5 | Offering prospectus | DocumentIndex |
| Apr 14, 2025 | 10-Q | Quarterly report | DocumentIndex |
| Feb 5, 2025 | 8-K | Material event | DocumentIndex |